Diane Weiser | Senior Vice President of Corporate Communications and Investor Relations |
Robert Blum | President and Chief Executive Officer |
Fady Malik | Executive Vice President of R&D |
Stuart Kupfer | Senior Vice President and Chief Medical Officer |
Robert Wong | Vice President and Chief Accounting Officer |
Ching Jaw | Senior Vice President and Chief Financial Officer |
Andrew Callos | Chief Commercial Officer |
Jason Butler | JMP Securities |
Dane Leone | Raymond James |
Carter Gould | Barclays |
Salim Syed | Mizuho |
Chad Messer | Needham & Company |
Jeff Hung | Morgan Stanley |
Emanuela Branchetti | H.C. Wainwright |
Graig Suvannavejh | Goldman Sachs |
Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics' Second Quarter 2021 Conference Call. At this time, I would like to inform you that this call is being recorded and that all participants are in a listen-only mode. At the company's request, we will open the call for questions-and-answers after the presentation. I will now like to turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.